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Abstract 
Background: There is rare reports about opinions and clinical practice of functional movement disorders (FMD) in 
China. The present survey aimed to investigate the views of FMD in Chinese clinicians.
Methods: The Chinese version survey of FMD were conducted in nationwide practitioners by means of an online 
questionnaire.
Results: Four hundred and thirty‑four Chinese clinicians completed a 21‑item questionnaire probing diagnostic and 
management issues in FMD. More than 80% of respondents considered that atypical movement disorder, multiple 
somatizations, and emotional disturbance were essential or absolutely necessary for clinically definite diagnosis of 
FMD. About three quarters of respondents requested standard neurological investigations to rule out organic causes. 
Over half believed that prior diagnosis of an organic disorder (59.9%), lack of associated non‑physiologic deficits 
(51.8%), and evidence of physical injury (50.0%) were ‘very influential’ or ‘extremely influential’ for a non‑FMD diagno‑
sis. The majority (77.4%) of the respondents may refer patients to a neuropsychiatrist or psychiatrist experienced in 
FMD, followed by psychologist or psychotherapist experienced in FMD (53.2%). However, lack of guidelines, physician 
knowledge, and training often limited clinicians’ ability in managing patients with FMD. Early diagnosis of FMD, iden‑
tification and management of concurrent psychiatric disorder, and acceptance of the diagnosis by the patient were 
considered most important for predicting a favorable prognosis.
Conclusions: Opinions and clinical practice of Chinese practitioners not only varied among Chinese neurologists, 
but also differed from international peers. Combined efforts are needed to promote related research and establish 
practice guidelines in China in the future.
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Backgrounds
Functional movement disorders (FMD), also known as 
psychogenic movement disorders (PMD) and conver-
sion disorders [1], are involuntary movements often 
attributed to psychological causes [2]. In the past, the 
term ‘hysteria’ was often used to describe these dis-
orders. FMD are a common source of disability, and 
specific prevalence of FMD remains unclear so far. 
Females (60–75%) are more affected than males except 
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for specific subtypes (e.g., functional myoclonus) 
[3]. Neurobiological mechanisms of FMD are not so 
clear but abnormalities of attentional focus, belief and 
expectations, and sense of agency might be involved 
[4]. Furthermore, overactivity of the limbic system and 
increased connections to the motor system play a role in 
pathophysiology of FMD as well [5]. Even though there 
are an increasing number of positive diagnostic criteria, 
the diagnosis of FMD is still challenging in the present. 
The Diagnostic and Statistical Manual of Mental Dis-
orders (DSM)-5 indicates that emphasis should be put 
on positive clinical characteristics rather than related 
psychological factors [6]. Previously, two investigations 
of opinions and clinical practice of FMD at an interval 
of one decade (2008 and 2018 respectively) were per-
formed for members of the International Parkinson and 
Movement Disorder Society (MDS). Interesting changes 
of attitudes and management of FMDs have been found, 
but gaps remained in access to diagnosis and treatment 
[7, 8]. However, there is rarely known about opinions 
and clinical practice of FMDs by Chinese clinicians. The 
present survey aimed to investigate the views of FMD 
in Chinese clinicians, predominately neurologists and 
movement disorders specialists, and reveal the current 
status concerning FMDs in the clinical setting in China.
Methods
FMD questionnaire
The Chinese version of a 21-item FMD questionnaire 
(Additional file 1) was authorized and adapted from the 
recent MDS version [8]. A group of experts were served 
as external reviewers to ensure content and face valid-
ity of the survey (8 academic neurologists with exper-
tise in movement disorders and 1 academic psychiatrist 
were included. Detailed information about affiliations 
was listed in Table  S1). After multiple reviews of these 
experts and modifications based on suggestions, an 
online tool (www. wjx. cn) was used to create and issue 
the questionnaire. URL address and QR code were 
shared to target clinicians via Wechat and the online 
survey was available for 2 weeks. Only practitioners who 
may be exposed to FMD were asked to complete the 
questionnaire. Participants were asked to complete the 
questionnaire within 2 weeks.
Statistical analysis
SPSS 22.0 was used to perform statistical analysis on 
downloaded data. For descriptive analysis, Chi-Square 
tests were used in comparison of frequencies and pro-
portions. Average ratings were calculated in Likert scale 
data. Spearman correlation analysis was performed within 




A total of 434 respondents accomplished the anonymous 
questionnaire within 2 weeks. Males made up 47.5%, 
and respondents over age of 45 years old accounted for 
nearly a half. They were from 29 provinces/ municipali-
ties / autonomous regions in China and demographic 
information can be found in Fig. S1. Approximately 90% 
of all respondents were from departments of Neurology 
or Movement Disorders (MDs) Clinics, and over half 
practiced less than 5 years in MDs subspecialty. Three 
quarters of the respondents were practiced in Tertiary 
hospitals. Detailed demographic characteristics were 
listed in Table 1.
Among the respondents, the majority acknowledged 
that they assessed no more than 3 FMD patients per 
month. Only a minority (18.5%) reported more than 
three FMD patients seen monthly. Meanwhile, a similar 
proportion (17.7%) were uncertain about the number 
of FMD patients they assessed. The number of FMD 
patients correlated with the number of patients with all 
movement disorders seen in clinic monthly (r = 0.248, 
p < 0.01). In addition, respondents who experienced fel-
lowship training in movement disorders or with longer 
years in practice reported more FMD patients seen per 
month (Table 2). When it comes to their responsibility 
of assessing patients with FMD, the substantial major-
ity (94.5%) believed that their role was not only just to 
provide a diagnosis, but also included coordinate inter-
disciplinary management or personal management.
Reaching the diagnosis
In this present survey, more than 80% of respondents 
considered that incongruent movement disorder, mul-
tiple somatizations, and emotional disturbance were 
essential or absolutely necessary for a clinically defi-
nite diagnosis of FMD (Fig. S2). Respondents tended to 
use suggestion to document and diagnose FMD more 
than placebo (often and always: 29.5% versus 17.7%) 
(Fig. S3).
In the case of unequivocal clinical features, about 
three quarters of respondents requested standard neu-
rological investigations with the aim to rule out organic 
causes. About half (58.1%) requested neurological 
investigations after which they informed the patients 
about the diagnosis of FMD, while others (16.1%) did 
not inform the patient of FMD diagnosis or psychogenic 
causation. Only 9% of the respondents were confident 
about making diagnosis (They directly informed the 
patient about the diagnosis in initial assessment without 
requesting neurological investigations) (Fig. 1). Approx-
imately 10% responded that they have no access to elec-
trophysiology testing or deemed it useless in diagnosis 
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of FMD. Majority of the rest respondents use the testing 
in uncertain cases (clinical examination alone is insuf-
ficient) or clinically definite FMD cases to confirm diag-
nosis. The other 16% apply electrophysiology testing in 
all cases. About two thirds of respondents use testing 
results sometimes (35.5%), often (24.7%), and always 
(4.4%) to explain the diagnosis to the patient.
Some of the respondents reported that a potential 
comorbid organic neurologic disorder was discovered in 
diagnosed FMD patients sometimes (35.9%) or frequently 
(1.8%). Meanwhile, more than half of all respondents 
worried about potentially ignorance of another organic 
disorder in patients with FMD.
Predictors for diagnosis other than FMD
Over half believed that prior diagnosis of an organic 
disorder provided by a reliable neurologist (59.9%), 
lack of associated non-physiologic deficits (51.8%), and 
evidence of physical injury (50.0%) were ‘very influen-
tial’ or ‘extremely influential’ for a non-PMD diagnosis. 
Meanwhile, gender seemed not important for diagnosis 
(Fig. 2A). Normal social or personal function was associ-
ated with normal work load (r = 0.564, p < 0.01), lack of 
psychiatric history or psychological stressor (r = 0.449, 
p < 0.01). Evidence of physical injury was correlated 
to lack of non-physiologic deficits (r = 0.506, p < 0.01), 
and lack of psychiatric history or psychological stressor 
(r = 0.411, p < 0.01).
Management
A majority (77.4%) of the respondents may refer 
patients to a neuropsychiatrist or psychiatrist expe-
rienced in FMD, followed by psychologist or psycho-
therapist experienced in FMD (53.2%) (Fig.  S4). Few 
respondents reported that their original diagnosis of 
FMD was questioned by psychiatrists, psychologists, 
rehabilitation specialists often (4.4%) or always (0.7%). 
A minority of respondents paid more attention on the 
treatment of FMD than on that of organic disorders. 
Respondents tended to prioritize treatment of symp-
toms that mainly led to disability, regardless whether 
they were thought organic or functional (52.3%). About 
30% of them put diagnosis and treatment organic disor-
der in the first place.
Opinions on effectiveness of various treatment strate-
gies differed. Taken together, psychotherapy with antide-
pressant/anxiolytic treatment was believed to be the most 
effective as nearly 60% respondents rated it as ‘very effec-
tive’ or ‘extremely effective’. Effectiveness of avoiding iatro-
genic harm and educating the patient were ranked second 
and third, respectively, and in high association (r = 0.702, 
p < 0.01). By contrast, psychotherapy without antidepres-
sant/anxiolytic treatment was thought less effective than 
Table 1 Demographics and overall practice of all respondents
a Fellowship training: training of the refresher doctors in subspecialty of MDs
b number of years engaged in PD outpatient or predominately engaged in 
diagnosis and treatment of MDs
c Other departments (11.5%) included internal medicine (5.0%), psychiatry 
(3.0%), and rehabilitation or functional neurosurgery (3.5%)
Descriptions N %
Gender
 Male 206 47.5
 Female 228 52.5
Age
 25‑35y 76 17.5
 36‑45y 144 33.2
 46‑55y 172 39.6
 56‑65y 40 9.2
  > 65y 2 0.5
Fellowship  traininga
 None 186 42.9
 1y 89 20.5
 2y 20 4.6
  ≥ 3y 139 32.0
Years of practice in  MDsb
  ≤ 5y 266 61.3
 6‑10y 79 18.2
 11‑15y 38 8.8
 16‑20y 19 4.4
  ≥ 21y 32 7.4
Department of hospital
 Neurology (General) 322 74.2
 Movement Disorders 62 14.3
  Othersc 50 11.5
Number of FMD patients seen per month
  < 1 134 30.9
 1–3 143 32.9
 4–6 51 11.8
 7–10 13 3.0
  > 11 16 3.7
 Uncertain 77 17.7
Number of all MD patients seen per month
  < 30 234 53.9
 30–45 74 17.1
 46–60 24 5.5
 61–80 10 2.3
  > 80 26 6.0
 Uncertain 66 15.2
Role or responsibility is in assessing FMD
 Provide only a diagnosis 24 5.5
 Diagnose and secure expert management 198 45.6
 Diagnose and coordinate interdisciplinary long‑term management 177 40.8
 Diagnose and manage the care personally 35 8.1
Personal preference in taking care of patients with FMD
 Very much look forward to 53 12.2
 Somewhat look forward to 86 19.8
 Neither looking forward to nor dislike 188 43.3
 Somewhat dislike 97 22.4
 Very much dislike 10 2.3
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other treatment strategies (Fig.  2B). When educating a 
patient about the FMD diagnosis, the respondents mostly 
discussed potential for reversibility/improvement and 
possible psychological factors (Fig. 2D).
Management ability of clinicians was generally (‘often’ 
or ‘always’) restricted by lack of treatment guide-
lines (47.2%), and less related knowledge and training 
(37.9%). The two limitations were related to each other 
(r = 0.570, p < 0.01). Insurability and litigation of FMD 
were deemed as limitations less frequently (Fig. 2C).
Predictors of prognosis
Early diagnosis of FMD, identification and management 
of concurrent psychiatric disorder, and acceptance of the 
diagnosis by the patient played important roles in a bet-
ter prognosis (Fig. 3). In the contrast, lack of ongoing liti-
gation, supportive social network, and paroxysmal type 
might be minor predictors.
Terminology and other concerns
The most common terminology remained ‘psychogenic 
movement disorder’ in the present study. Additionally, 
‘functional movement disorder’ and ‘functional somatic 
syndrome’ were also endorsed in experts’ communi-
cation. ‘Psychosomatic disorder’ was often used as lay 
term. Other terms are illustrated in Fig.  4. Among all 
respondents, 16.4% (71/434) answered the open-ended 
question about other unsolved issues important in FMD 
(Table S2).
Discussion
The present investigation revealed a clear picture of cur-
rent views of FMD, and found that opinions and clinical 
practice of FMD varied widely among Chinese clinicians 
for the first time. This could be partially explained by lack 
of diagnosis/treatment guidelines and physician knowl-
edge, which were also taken as important limitations in 
Table 2 Fellowship training and years of practice in MDs have an influence on number of FMD patients assessed per month




Length of fellowship training
 none 160 (45.2%) 26 (32.5%) X2 = 4.296
P = 0.038 1–3 years or longer 194 (54.8%) 54 (67.5%)
Years of practice in MDs subspecialty
  < 5 years 235 (66.4%) 31 (38.8%) X2 = 21.003
P = 0.000 6–21 years or longer 119 (33.6%) 49 (61.3%)
Fig. 1 Approach to delivering the diagnosis in clinically definite FMD
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management of FMD. Meanwhile, both general neurolo-
gists and subspecialists of MDs were recruited in this 
survey. Considering that the practitioners with more 
experience in MD reported more FMD patients assessed 
monthly (Table 2), it is supposed that these practitioners 
were more familiar with diagnosis of FMD.
Fig. 2 Opinions and clinical practice about diagnosing and managing FMD. Catalogues were listed in descending order by average ratings. 
Intensity of color indicates the extent of agreement (dark orange) or disagreement (light orange). A Influence of predictors for non‑FMD diagnosis; 
B Effectiveness of treatment strategies of FMD; C Restrictions in managing patients with FMD; D Educating the patient about FMD diagnosis
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Compared to the latest survey conducted in members 
of International MDS (summarized in Table 3) [8], there 
were differences in results of the present survey. Despite 
the term having shifted to ‘Functional movement dis-
orders’ in recent years, the Chinese expression of ‘psy-
chogenic movement disorders’ was endorsed by most 
clinicians. However, opinions and clinical approaches 
differed in diagnosis, treatment, and prognosis. The 
selective bias should be taken into consideration. Most 
respondents investigated in the survey of International 
MDS were academic clinicians/researchers interested 
in FMD, and were fellowship trained in subspecialty of 
MDs. Whereas more general neurologists were surveyed 
in the present survey. Furthermore, different practice 
patterns could not be ignored as indicated in the previous 
surveys [7, 8].
Despite some significant differences between the pre-
sent study and the previous MDS study, some points 
of view were similar. For instance, more than half of 
the respondents worried about the potential of miss-
ing another organic disorder in patients with FMD. 
Additionally, the respondents tended to believe that an 
incongruent movement disorder was necessary/essen-
tial for clinically definite FMD. In terms of indicat-
ing non-FMD diagnosis, a prior organic diagnosis and 
physical injury were endorsed by both sides. Avoiding 
iatrogenic harm and educating the patient were con-
sidered very or extremely effective in treating patients 
with FMD by practitioners at home and abroad. The 
clinicians’ ability in managing FMD patients was often 
restricted by lack of treatment guidelines and cultural 
beliefs about psychological illnesses. Identification 
and treatment of concurrent psychiatric disorder and 
acceptance of the diagnosis by the patient were crucial 
for predicting a better prognosis. Regarding patient 
education, discussion about potential for reversibility/
improvement and possible psychological factors were 
usually adopted.
Fig. 3 Importance of predictors for a better prognosis of FMD. Catalogues were listed in descending order by average ratings
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Challenges in diagnosis
A great proportion of respondents put emphasis on the 
presence of multiple somatizations and emotional dis-
turbance in diagnosing a definite FMD. This might indi-
cate a misunderstanding of FMD since the fifth version 
of Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5) indicated the importance of making a ‘positive’ 
diagnosis rather than emphasizing precipitating stress-
ors [6]. Neurological examination which demonstrates 
inconsistency and/or incongruence can be essential to 
establish a positive diagnosis [9]. Additionally, only 9% of 
the practitioners informed the patients of certain diagno-
sis during initial assessment and did not request standard 
neurological investigations while nearly 75% requested 
investigations before or not informing patients of the 
diagnosis. Based on this evidence, it is inferred that only 
few of the respondents were good at diagnosing FMD. 
It is also reflected by the number of patients with FMD 
assessed per month in clinics by the respondents. A con-
siderable proportion of respondents reported less than 3 
or were uncertain about it.
Electrophysiology testing was more widely used in 
the present survey. In this condition, Chinese clinicians 
explained the results of electrophysiological testing 
to patients a little more often. It was also reported 
that electrophysiological testing was more commonly 
applied outside the USA. Electrophysiology testing 
proved useful in supporting diagnosis of FMD, espe-
cially subtype of tremor. But for cases with long-term 
or mixed with organic disorder, it might not be sup-
portive [10].
A substantial proportion of respondents were con-
cerned about missing a potential organic diagnosis in the 
both present survey (55.7%) and previous survey (64%). 
In fact, a meta-analysis indicated that the rate of misdi-
agnosis of conversion symptoms had declined to about 
4% since 1970 [11]. It seems that this level of worry is 
unnecessary.
Challenges in management
The results showed different referral preferences 
(Neuropsychiatrist or psychiatrist focused on FMD vs 
General psychiatrist) between Chinese clinicians and 
international MDS members. Considering the treat-
ment of FMD, psychotherapy with antidepressant/ 
anxiolytic treatment was rated the most effective by 
Chinese clinicians, which differed from the survey con-
ducted by MDS where avoiding iatrogenic harm was 
Fig. 4 Terms used in medical communications and lay public. The preferred terms in communicating with medical professionals (blue) and lay 
public (orange) when respondents were asked to select the top three
Page 8 of 10Xie et al. BMC Neurology          (2021) 21:435 
endorsed by most respondents. The related favora-
ble evidence was sparse. One small-sized clinical trial 
found that patients with primary conversion symptoms 
and with depression or anxiety may respond to antide-
pressant drugs [12]. Other previous research suggested 
some treatment strategies that might be effective. 
For example, physical therapy might contribute to 
Table 3 Differences between results of this Chinese survey and that of recent MDS survey (percentages of respondents)
Note: The blank cells indicate the differences of top options between the two surveys. For instance, incongruent MD, multiple somatizations, and emotional 
disturbance ranked top three necessary for Chinese neurologist in opinions of clinically definite FMD, whereas incongruent MD, functional signs, and inconsistent over 
time were endorsed by most MDS members
Descriptions Chinese survey Recent MDS survey (2018)
More than 3 FMD patients seen monthly 18.5% 34%
Identifying a comorbid organic neurological disorder ‘sometimes’ or ‘frequently’ 37.7% 41%
Concerned about missing another organic diagnosis in FMD patients 55.7% 64%
Role and responsibility (more than providing a diagnosis) 94.5% 99.1%
Disliking seeing FMD patients 24.7% 29%
Necessary for clinically definite FMD (top three)
 Incongruent MD 84.8% 60.7%
 Multiple somatizations 82.3%
 Emotional disturbance 80.9%
 Functional signs 78.1%
 Inconsistent over time 51.6%
Use suggestion to assist with diagnosis 29.5% 43.1%
Use placebo to assist with diagnosis 17.7% 8.8%
Request neurological investigations before diagnosing 58.1% 47%
Electrophysiology for confirmation 89.8% 60%
Discuss results of the electrophysiology testing with patients (‘often’ and ‘always’) 29.1% 21.2%
Non‑FMD diagnosis indicators (top three)
 A prior organic diagnosis 60% 43%
 Lack of non‑physiologic deficits 52%
 Physical injury 50% 37%
 Extremes of age 36%
Refer patients
 Neuropsychiatrist or psychiatrist experienced in FMD 77.4%
 General Psychiatrist 56%
Very and extremely effective treatments (top three)
 Psychotherapy with antidepressant/ anxiolytic treatment 59.2%
 Avoiding iatrogenic harm 35.5% 58%
 Educating the patient 32.7% 53%
 Rehabilitation services 40%
Limitations in managing patients
 Lack of treatment guidelines 47.3% 39%
 Physician knowledge/training 32.9%
 Cultural beliefs about psychological illnesses 27.2% 50%
 Availability of referral services 48%
Important for indicating a better prognosis (top three)
 Early diagnosis of FMD 76.2%
 Identification and management of concurrent psychiatric disorder 72.6% About 85%
 Acceptance of the diagnosis by the patient 65.0% More than 90%
 Identification and management of psychological stressors About 84%
Educating a patient (‘most of the time’ and ‘always’)
 Discuss potential for reversibility/improvement 56.2% 90%
 Discuss possible role psychological factors 53.7% 85%
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improvement of symptoms [13–15]. Physiotherapy was 
recommended in definite FMD patients who desired 
improvement and serve as the foundation of psycholog-
ical treatment. The related consensus emphasized the 
importance of physiotherapy and occupational therapy 
in the multidisciplinary management of patients with 
FMD [16, 17]. Therefore, rehabilitation services played 
a key role in the intervention of FMD, but they were 
ignored to some extent in clinical practice in China. In 
addition, another research found cognitive behavioral 
therapy (CBT) effective in alleviating specific motor 
symptoms, as well as depression and anxiety [18]. 
Contrarily, the adjunctive physical activity (APA) did 
not achieve satisfactory improvements [18]. The main 
disadvantages of these studies were the small size and 
recruitment of different types of movement disorder. 
Further studies should be conducted in large samples to 
verify the effectiveness of the therapies. Other potential 
treatments included multidisciplinary treatment, trans-
cutaneous electrical stimulation and others [3].
Avoiding iatrogenic injury and patient education 
were emphasized again in this present survey. It was 
generally accepted that the treating process starts from 
delivering the diagnosis of PMD to the patient [3, 19]. 
Demonstrating the positive physical signs and talking 
with the patient about the potential for reversibility 
were highly appreciated, but a minority of the respond-
ents explained the positive signs when educating 
the patient. Acceptance of the FMD diagnosis by the 
patient counted most in predicting a better prognosis 
in previous surveys [7]. However, most domestic clini-
cians were in favor of early diagnosis as predictor for 
a better prognosis. It was inconclusive but with a few 
supportive evidences [20]. Overall, outcomes of FMD 
seems unfavorable [20].
Limitations
Sampling bias existed as more neurologists with less 
experience in MDs subspecialty were recruited in this 
present survey. In this condition, the results might rep-
resent the general perceptions related to FMD in Chi-
nese neurological clinicians. In addition, no-response 
bias also should be considered. The response rate was 
difficult to calculate because separate emails were not 
adopted to target respondents.
Conclusions and recommendations
Opinions and clinical practice of Chinese practitioners 
not only varied among Chinese clinicians, but also dif-
fered from international peers. Chinese neurologists have 
insufficient knowledge of FMD, especially those with 
shorter clinical practice. FMD was generally neglected. 
We recommend to raise awareness of FMD in following 
aspects:
1) It is necessary to set up Chinese (translated or modi-
fied) version of the diagnostic criteria of FMD. Chi-
nese diagnostic criteria may conduce to the clinical 
practice of neurologists.
2) A lack of treatment guidelines represents an impor-
tant limitation in the management of patients with 
FMD. However, studies on effectiveness of treat-
ing FMD are scant in China. Combined efforts are 
needed to promote related research and establish 
guidelines.
3) It is necessary to decide whether to use ‘functional 
movement disorder’ instead of ‘psychological move-
ment disorder’ in Chinese terminology, which would 
be in line with international standards.
4) FMD should be added to fellowship training and 
teaching period in China.
5) Except for FMD, the diagnosis/treatment of psycho-
genic nonepileptic seizures (PNES) or pseudo(−)
seizure(s) are needed to be better understood as well 
in the future.
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